Detalhe da pesquisa
1.
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Blood
; 2024 May 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38717861
2.
Randomized phase III GnG study on two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and double-blinded intensive post-remission therapy with or without glasdegib in patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 2024 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38385304
3.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37542108
4.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35678031
5.
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol
; 102(2): 349-358, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36564535
6.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol
; 102(10): 2741-2752, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37592092
7.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33191481
8.
Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility.
Eur J Haematol
; 107(3): 324-332, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-34022082
9.
Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML).
Ann Hematol
; 98(6): 1393-1401, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30903275
10.
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition.
Haematologica
; 108(4): 1179-1185, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36453102
11.
Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER).
Haematologica
; 108(8): 2244-2248, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36601981
12.
Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis.
Eur J Haematol
; 101(3): 305-317, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29791053
13.
Bosutinib: A Potent Second-Generation Tyrosine Kinase Inhibitor.
Recent Results Cancer Res
; 212: 87-108, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30069626
14.
Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas.
Int J Mol Sci
; 19(2)2018 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-29463038
15.
Evidence for a pre-existing telomere deficit in non-clonal hematopoietic stem cells in patients with acute myeloid leukemia.
Ann Hematol
; 96(9): 1457-1461, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28674830
16.
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(8): 2141-2142, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34160650
17.
A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia.
Eur J Haematol
; 97(1): 17-24, 2016 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-26277604
18.
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 105(5): e228-e231, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31413097
19.
Application of wearables for remote monitoring of oncology patients: A scoping review.
Digit Health
; 10: 20552076241233998, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38481796
20.
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1).
Biochim Biophys Acta Gene Regul Mech
; 1867(1): 195004, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38008244